10-95067362-TA-TAAA
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP6
The NM_000770.3(CYP2C8):c.332-6_332-5insTT variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000725 in 1,613,588 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., cov: 19)
Exomes 𝑓: 0.000064 ( 1 hom. )
Consequence
CYP2C8
NM_000770.3 splice_region, splice_polypyrimidine_tract, intron
NM_000770.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.927
Genes affected
CYP2C8 (HGNC:2622): (cytochrome P450 family 2 subfamily C member 8) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BP6
Variant 10-95067362-T-TAA is Benign according to our data. Variant chr10-95067362-T-TAA is described in ClinVar as [Likely_benign]. Clinvar id is 3043359.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP2C8 | NM_000770.3 | c.332-6_332-5insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000371270.6 | NP_000761.3 | |||
CYP2C8 | NM_001198853.1 | c.122-6_122-5insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001185782.1 | ||||
CYP2C8 | NM_001198854.1 | c.26-6_26-5insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001185783.1 | ||||
CYP2C8 | NM_001198855.1 | c.122-6_122-5insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001185784.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2C8 | ENST00000371270.6 | c.332-6_332-5insTT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000770.3 | ENSP00000360317 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151688Hom.: 0 Cov.: 19
GnomAD3 genomes
AF:
AC:
22
AN:
151688
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000124 AC: 31AN: 250816Hom.: 1 AF XY: 0.000140 AC XY: 19AN XY: 135652
GnomAD3 exomes
AF:
AC:
31
AN:
250816
Hom.:
AF XY:
AC XY:
19
AN XY:
135652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461780Hom.: 1 Cov.: 37 AF XY: 0.0000743 AC XY: 54AN XY: 727194
GnomAD4 exome
AF:
AC:
94
AN:
1461780
Hom.:
Cov.:
37
AF XY:
AC XY:
54
AN XY:
727194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000152 AC: 23AN: 151808Hom.: 0 Cov.: 19 AF XY: 0.000202 AC XY: 15AN XY: 74146
GnomAD4 genome
AF:
AC:
23
AN:
151808
Hom.:
Cov.:
19
AF XY:
AC XY:
15
AN XY:
74146
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CYP2C8-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 20, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at